By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: AbbVie, Angel Investors Restock Nanomedicine Leader Chad Mirkin’s Pharma Venture
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Business > Finance > AbbVie, Angel Investors Restock Nanomedicine Leader Chad Mirkin’s Pharma Venture
BusinessFinance

AbbVie, Angel Investors Restock Nanomedicine Leader Chad Mirkin’s Pharma Venture

Deanna Pogorelc
Deanna Pogorelc
Share
2 Min Read
SHARE

nano medicine

Originally published on MedCityNews.com.

For a Northwestern University biopharmaceutical spinoff, a second tranche of Series B funding will push along pre-clinical development of gene-regulating therapies for multiple diseases.

nano medicine

More Read

Alternative to ACO
Don’t Like the Sound of ACOs? Here’s an Alternative
The Trials of Progress in the Affordable Care Act
Using Content Marketing to Deliver Inbound Patient Prospects
Top 7 Reasons a Busy Doctor Needs a Powerful Website
Health Care Buzz Today

Originally published on MedCityNews.com.

For a Northwestern University biopharmaceutical spinoff, a second tranche of Series B funding will push along pre-clinical development of gene-regulating therapies for multiple diseases.

AuraSense Therapeutics isn’t disclosing how much was raised in the second tranche of its Series B, but the company says funding came from AbbVie Inc. and angel investors including David Walt, a co-founder of Illumina, and Craig Mundie, senior advisor to the CEO at Microsoft.

According to SEC filings, AuraSense first secured $5.4 million in Series B funds back in 2011.

The startup is developing a platform for nucleic-acid based therapeutics with applications in oncology, dermatology, neurology and for immune disorders. It says its spherical nucleic acid (SNA) conjugates overcome the greatest obstacles to gene regulation: they don’t need carrier agents, they provoke minimal immune response and they have no known toxicity.

The technology is based on gold nanoparticles, which have also formed the foundation of several other drug companies’ platforms because of their accessibility, versatility and ability to attach easily to other molecules. AuraSense’s differentiator? Its scientific co-founder, Chad Mirkin, is a pioneer in the field of nanomedicine. He developed the first SNA constructs nearly two decades ago and has since founded four companies based on the technology. The FDA-cleared Verigene System, a diagnostic tool used to identify infectious disease and cancers, is based on SNAs.

AuraSense Therapeutics was formed as a subsidiary of another Mirkin company, AuraSense LLC, in 2011. Co-founder C. Shad Thaxton is a faculty member at Northwestern’s Feinberg School of Medicine.

TAGGED:health start-ups!pharma
Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5kFollowersLike
4.5kFollowersFollow
2.8kFollowersPin
136kSubscribersSubscribe

Latest News

Epidemiological Health Benefits
Personal and Epidemiological Health Benefits of Blood Pressure Management
Health
October 13, 2025
Traumatic Brain Injuries
Understanding Traumatic Brain Injuries: What Families Need to Know
Policy & Law
October 10, 2025
Remote Monitoring touchpoints
Remote Monitoring Touchpoints Patients Will Actually Follow
Technology
October 9, 2025
dental care
Importance of Good Dental Care for Health and Confidence
Dental health Specialties
October 2, 2025

You Might also Like

Wireless Devices Will Dramatically Change How Medicine Is Practiced

December 2, 2011

Renowned Dallas Hospital Out of Medicare Compliance

September 3, 2011

Report: Avoidable ‘Never Events’ Increase in Minnesota Hospitals

January 20, 2012
workers comp ICD10 his
BusinessFinanceHealth ReformHospital AdministrationMedical RecordsPublic Health

Workers’ Compensation and ICD-10

May 18, 2013
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2025 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?